A NON-INVASIVE, ADAPTIVE DIGITAL THERAPEUTIC SOLUTION FOR POST-TRAUMATIC STRESS DISORDER AND OTHER MENTAL DISORDERS
GrayMatters aims to treat PTSD using a non-invasive, machine-learning-based EEG-Neurofeedback device to help patients control amygdala activity, showing promising clinical results.
Projectdetails
Introduction
Post-traumatic stress disorder (PTSD) is a severe mental disorder, annually affecting 3.2% of the population, with a global market size estimated at €7.5B. Current treatments’ success is marginal, costly, and associated with severe side effects.
Innovation
GrayMatters is the first to introduce a non-invasive digital therapeutics device that harnesses brain plasticity to help PTSD patients control abnormal brain-region activity. Our patented innovation uses machine learning to convert EEG signals to an fMRI-like signal of the amygdala, enabling patients to learn to self-control their amygdala activity level using an affordable EEG-Neurofeedback device.
Clinical Trials
Initial clinical trials on stress resilience and PTSD patients showed significant positive clinical results.
Team Experience
The founders have over 25 years of experience in commercialization, healthcare, and technology, with several startup exits and IPOs.
Partnerships
Letters of Intent (LOIs) include top mental institutes and world-renowned Key Opinion Leaders (KOLs) in PTSD psychiatry.
Recognition
GrayMatters was recently chosen as one of 8 innovative companies by Nature magazine.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.500.000 |
Totale projectbegroting | € 3.594.250 |
Tijdlijn
Startdatum | 1-9-2022 |
Einddatum | 31-5-2025 |
Subsidiejaar | 2022 |
Partners & Locaties
Projectpartners
- GRAYMATTERS HEALTH LTDpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Accelerator
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
A new cardioprotective drug for acute treatment of myocardial infarctionResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Clear, scalable and scientific framework to measure terrestrial biodiversity3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value. | EIC Accelerator | € 2.252.714 | 2024 | Details |
Novel and Scalable microbial products for REgenerative agricultureN-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency. | EIC Accelerator | € 2.499.999 | 2024 | Details |
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data SecurityQuside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors. | EIC Accelerator | € 2.499.999 | 2024 | Details |
A new cardioprotective drug for acute treatment of myocardial infarction
ResoTher aims to validate RTP-026, an immunomodulating therapy, to reduce heart damage and HF risk post-myocardial infarction through Phase II clinical studies.
Clear, scalable and scientific framework to measure terrestrial biodiversity
3Bee leverages IoT, wildlife monitoring, and satellite data to measure and regenerate biodiversity, generating certified Biodiversity Credits for corporations to enhance ESG reporting and brand value.
Novel and Scalable microbial products for REgenerative agriculture
N-Spire aims to revolutionize agriculture by creating a sustainable bioactive fertilizer through innovative manufacturing techniques, enhancing soil health and reducing chemical dependency.
Quantum-based Randomness Processing Units (RPUs) for High-Performance Computation and Data Security
Quside's Randomness Processing Unit (RPU) accelerates stochastic HPC and PQ cryptography by optimizing random workloads, enhancing efficiency and performance across various sectors.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental HealthThis project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders. | ERC COG | € 1.999.875 | 2025 | Details |
60-Hz light entrainment to unlock mental health conditionsThis project aims to develop a non-invasive light-based therapy to enhance cognitive function by targeting the perineuronal net in mice, with potential applications for anxiety and PTSD treatment. | ERC POC | € 150.000 | 2024 | Details |
AlphaBeatsAlphaBeats ontwikkelt een digitale meditatie-app die biofeedback en muziek combineert om stress te verminderen, met als doel de haalbaarheid van EEG-sensoren voor een zelflerend algoritme te onderzoeken. | MIT Haalbaarheid | € 20.000 | 2021 | Details |
Angststoornissen te lijf met E-HealthMind Mansion ontwikkelt een locatie-onafhankelijk VR-platform voor de behandeling van angststoornissen, gericht op het verbeteren van zorgbeleving en geestelijke gezondheid via innovatieve technologieën. | MIT Haalbaarheid | € 20.000 | 2020 | Details |
Bidirectional Brain/Neural-Computer Interaction for Restoration of Mental Health
This project aims to develop a portable neuromodulation system using quantum sensors and magnetic stimulation to precisely target brain oscillations for treating mental health disorders.
60-Hz light entrainment to unlock mental health conditions
This project aims to develop a non-invasive light-based therapy to enhance cognitive function by targeting the perineuronal net in mice, with potential applications for anxiety and PTSD treatment.
AlphaBeats
AlphaBeats ontwikkelt een digitale meditatie-app die biofeedback en muziek combineert om stress te verminderen, met als doel de haalbaarheid van EEG-sensoren voor een zelflerend algoritme te onderzoeken.
Angststoornissen te lijf met E-Health
Mind Mansion ontwikkelt een locatie-onafhankelijk VR-platform voor de behandeling van angststoornissen, gericht op het verbeteren van zorgbeleving en geestelijke gezondheid via innovatieve technologieën.